Diane Lejeune

In a world where Neurological disorders will affect 1 person in 3 and where the number of parkinsons patient will double in the next decade, reaching 13 million patients. Our mission is to empower clinicians with Biomarkers allowing them to identify Neurological Disorders (Parkinsons Disease, Alzheimers Disease and Multiple Sclerosis) years before visible symptoms. Our ambition with NeuroClues is to become the brains stethoscope. We are a team of seasoned MedTech entrepreneurs and doctors with as purpose to help our healthcare system cross the chasm of technology with pragmatic solutions. We work from anywhere but our base camps are in Louvain-la-Neuve, Belgium & Paris, France & NY, USA. We’re are looking to connect with individuals, companies, investors and Key Opinion Leaders that share our ambition and mission and that would be willing to partner with us in order to bring NeuroClues to the EU and US market.

Bloomlife is an award winning women’s health company solving the most significant yet underserved global challenges today in maternal health. We are redefining the way prenatal care is delivered by combining connected devices with cloud based data analytics to improve access to care, empower women, and provide clinicians with information to more effectively screen and manage pregnancy complications. Our goal is to become the leading provider of remote care for expectant women globally. Bloomlife’s approach to managing high risk pregnancies allows obstetricians to more easily screen maternal and fetal risk, educate the patient, and quickly access high risk specialists regardless of a patient’s geography. Our solution represents a marked shift from the way high risk pregnancies have been historically assessed using frequent in person appointments, paper logs, and long referral times.

Introducing Morrow Eyewear: Revolutionizing Vision with Cutting-Edge Liquid Crystal Technology At Morrow Eyewear, we're pushing the boundaries of vision enhancement by integrating state-of-the-art liquid crystal technology into our premium eyewear products. Our innovative lenses are designed to deliver unparalleled comfort, adaptability, and performance to those who demand the best from their eyewear. Our dynamic liquid crystal lenses empower users to experience a seamless transition between varying distances, ensuring optimal vision and a stylish look in every situation. With Morrow Eyewear, you'll enjoy crystal-clear vision and remarkable convenience, all wrapped in a sleek and modern design. Welcome to the future of eyewear – Experience the Morrow difference today.

Introducing Morrow Eyewear: Revolutionizing Vision with Cutting-Edge Liquid Crystal Technology At Morrow Eyewear, we're pushing the boundaries of vision enhancement by integrating state-of-the-art liquid crystal technology into our premium eyewear products. Our innovative lenses are designed to deliver unparalleled comfort, adaptability, and performance to those who demand the best from their eyewear. Our dynamic liquid crystal lenses empower users to experience a seamless transition between varying distances, ensuring optimal vision and a stylish look in every situation. With Morrow Eyewear, you'll enjoy crystal-clear vision and remarkable convenience, all wrapped in a sleek and modern design. Welcome to the future of eyewear – Experience the Morrow difference today.

IGNITY, ex-WSL, est le premier incubateur technologique d’Europe. Il soutient les entrepreneurs à chaque étape de leur parcours — de la création d’entreprise au développement et à la croissance. Fort d’un taux de réussite de 92 %, il figure également dans le top 10 mondial. L’incubateur propose un accompagnement global et durable, couvrant des domaines clés comme le management, les finances, la logistique ou encore la communication. Il appuie actuellement 73 start-ups et spin-offs actives dans les secteurs des ICT et de l’IA, des medtech, des greentech, de l’industrie 4.0 et de l’électronique. Ensemble, ces entreprises génèrent un chiffre d’affaires de 35 millions d’euros et emploient près de 500 personnes. Les collaborations s’étendent généralement sur une période de 3 à 7 ans. Acteur clé de l’innovation technologique, IGNITY a été reconnu par l’OTAN comme l’un des neuf accélérateurs mondiaux agréés dans le cadre du programme DIANA (Defense Innovation Accelerator for the North Atlantic). Fondé en 2000 par le Gouvernement wallon et basé à Liège, il dispose également d’antennes dans les principales universités de Wallonie et de Bruxelles. En 2025, WSL devient Ignity. Ce nouveau nom est la contraction de ignite (enflammer) et unity (unité) : une nouvelle identité qui incarne notre mission depuis toujours, faire émerger les projets technologiques les plus ambitieux et fédérer les acteurs de la tech autour d’eux. 🔥

In a world where Neurological disorders will affect 1 person in 3 and where the number of parkinsons patient will double in the next decade, reaching 13 million patients. Our mission is to empower clinicians with Biomarkers allowing them to identify Neurological Disorders (Parkinsons Disease, Alzheimers Disease and Multiple Sclerosis) years before visible symptoms. Our ambition with NeuroClues is to become the brains stethoscope. We are a team of seasoned MedTech entrepreneurs and doctors with as purpose to help our healthcare system cross the chasm of technology with pragmatic solutions. We work from anywhere but our base camps are in Louvain-la-Neuve, Belgium & Paris, France & NY, USA. We’re are looking to connect with individuals, companies, investors and Key Opinion Leaders that share our ambition and mission and that would be willing to partner with us in order to bring NeuroClues to the EU and US market.

CD²ML is a consultancy company providing services to start-ups, scale-ups and Venture Capital funds Looking for support in strategy & raising funds from VC, GDPR and data strategy, or needing help for due diligence of innovative health tech or IT start-ups and scale-ups, you reached the right place. For more details on our services, visit our website or contact us at info@cd2ml.eu

PMV is een Vlaamse investeringsmaatschappij die investeert in de toekomst van de Vlaamse economie. Wij financieren beloftevolle ondernemingen en projecten van bij de prille start tot en met de groei en internationalisering. Bovendien leveren wij financieel maatwerk voor alle ondernemers met een degelijk plan en een goed team. Hiervoor putten onze honderd vijfentwintig professionele medewerkers uit ons beproefde arsenaal aan kapitaal, leningen en waarborgen. Met meer dan één miljard euro in te investeren activa zijn wij een slagkrachtige investeringsmaatschappij die zich met volle goesting achter uw ambities schaart. Zo zorgen wij, samen met u, en elke dag opnieuw, voor meer welvaart en welzijn in Vlaanderen.

CAPRICORN HEALTH-TECH FUND is a company based out of 19 Lei, Leuven, Belgium.